Vomiting News and Research

RSS

Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.

Universal vaccination associated with decreased Canadian cases of most deadly strain of meningitis

Universal childhood vaccination against meningococcal C appears to reduce Canadian incidence of the most deadly strain of bacterial meningitis, reports new research published in the March issue of The Pediatric Infectious Disease Journal.

2 Mar 2009

New cancer treatment stops aggressive sarcomas

After all standard treatments had failed, a new cancer treatment has stopped the growth of aggressive sarcomas in two recent patients. These results are similar to the new protocol's previous success against several cancers, including melanoma, pancreatic, colon, mesothelioma and other sarcomas.

25 Feb 2009

Back from the dead twice

“I died twice,” says a teary-eyed DeWayne Lark, “If I didn't believe in miracles before, I believe in them now.”

20 Feb 2009

Ondansetron shown to be a viable treatment option for opioid addiction

Scientists at Stanford University School of Medicine have discovered that a commonly available non-addictive drug can prevent symptoms of withdrawal from opioids with little likelihood of serious side effects.

18 Feb 2009

World experts meet in Australia to find ways to wipe out malaria

Australia is host to a meeting of World health experts which aims to find ways of eradicating malaria, one of the world's most dangerous killer diseases.

9 Feb 2009

Vitamin B and folic acid - a new and safe treatment for migraine

A new Australian study has revealed that the occurrence and intensity of migraine may be lessened by taking vitamin B and folic acid.

9 Feb 2009

Good news for folks is bad news for mozzies!

Australian scientists have good news for folks but bad news for 'mozzies' with the discovery a possible new treatment for malaria.

8 Feb 2009

Study finds vitamin use is highest in children who don't need them

A study by UC Davis researchers published in the February 2009 issue of the Archives of Pediatric & Adolescent Medicine has found that most of the healthy children and teenagers in the United States who are taking daily vitamin and mineral supplements probably don't need them.

2 Feb 2009

Vitamin and mineral supplement use high among U.S. children and teens

A large number of U.S. children and teens age 2 to 17 appear to use vitamin and mineral supplements, although most may not need them, according to a report in the February issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

2 Feb 2009

Magnesium sulphate protects babies against cerebral palsy

Giving pregnant mothers magnesium sulphate when they are at risk of very preterm birth can help protect their babies from cerebral palsy, according to an international review of research involving the University of Adelaide, Australia.

21 Jan 2009

CSL Behring receives FDA approval of RiaSTAP

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for RiaSTAP(TM), the first and only treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.

19 Jan 2009

Salmonella prompts recall of Kellogg's snacks

Food and Drug Administration (FDA) officials in the United States have confirmed the presence of salmonella in a popular snack made by food giant Kellogg.

19 Jan 2009

Calls for cash and fogging to curb spread of dengue fever

As the Dengue fever outbreak in northern Queensland continues to claim new victims on a daily basis, many are calling for more funding to control the spread of the disease with some suggesting the only answer will be a fogging campaign.

19 Jan 2009

Savella - Fibromyalgia treatment approved by FDA

Forest Laboratories, Inc. and Cypress Bioscience, Inc. have announced that Savella (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the management of fibromyalgia.

19 Jan 2009

New mouse model for peanut allergy

Chicago researchers report the development of a new mouse model for food allergy that mimics symptoms generated during a human allergic reaction to peanuts.

12 Jan 2009

Discovery of gene that increases susceptibility to Crohn's disease

Researchers at McGill University, the Research Institute of the McGill University Health Centre (RI MUHC) and the McGill University and Génome Québec Innovation Centre, along with colleagues at other Canadian and Belgian institutions, have discovered DNA variations in a gene that increases susceptibility to developing Crohn's disease.

8 Jan 2009

Phase III studies of EXPAREL (DepoBupivacaine) from Pacira complete enrollment

Pacira Pharmaceuticals, Inc., an acute care specialty pharmaceutical company, announced today that enrollment has been completed in two pivotal Phase III SIMPLE trials to evaluate the safety and efficacy of a single intraoperative administration of EXPAREL(TM) (DepoBupivacaine) for prolonged postoperative analgesia.

6 Jan 2009

Genetic mutation causes familial susceptibility for degenerative brain disease acute necrotizing encephalopathy

Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE).

6 Jan 2009

Bulimia linked to brain circuit abnormalities

Scientists in the U.S. are suggesting that women who suffer from bulimia nervosa may have an abnormality in the brain circuit.

6 Jan 2009

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).

From Baxter International Inc. 5 Jan 2009